Companies: 11,396     total market cap: โ‚ฌ131.333 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Genetic Technologies
GENE
#11116
Rank
โ‚ฌ3.31 M
Marketcap
๐Ÿ‡ฆ๐Ÿ‡บ Australia
Country
0,68ย โ‚ฌ
Share price
0.00%
Change (1 day)
-67.56%
Change (1 year)
โš•๏ธ Diagnostics and Testing๐Ÿงฌ Biotech
Categories

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2007 the company made an earnings per share (EPS) of -4,85ย โ‚ฌ an increase over its 2006 EPS that were of -15,45ย โ‚ฌ.

EPS history for Genetic Technologies from 2005 to 2018

Annual EPS

Year EPS Change
2018 (TTM)N/A
2007-4,85ย โ‚ฌ-68.58%
2006-15,45ย โ‚ฌ35.05%
2005-11,44ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
17,00ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
9,11ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
5,48ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
10,99ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
0,34ย โ‚ฌN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-0,22ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-1,07ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,22ย โ‚ฌN/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com